logo
What Does Medicaid Have To Do With Older Adults Anyway?

What Does Medicaid Have To Do With Older Adults Anyway?

Forbes22-04-2025
We soon will learn what Congress and the Trump Administration have in store for Medicaid. But while the state/federal program has become a high-profile target, it is widely misunderstood. And so are the consequences of major Medicaid changes for older adults, people with disabilities, and their families.
Yes, Medicaid provides medical insurance for low-income working age people and their children. But Medicaid spends more than half its budget on medical and long-term care for frail, low-income older adults and younger people with disabilities. And about one-quarter of all Medicaid benefits, more than $200 billion, goes to long-term care for about 9 million frail older adults and people with disabilities.
While Medicaid is a public insurance program, 94 million recipients get their benefits from private managed care organizations, or MCOs. A few are run by non profits but the vast majority are owned by insurance companies.
Those managed care companies often are responsible for both medical and long-term care for those known as dual eligibles, who qualify for both Medicaid and Medicare. About 60 percent of Medicaid LTSS beneficiaries received care through MCOs.
While many think Medicaid long-term care is provided only in nursing homes, 85 percent of Medicaid LTSS recipients get their care at home. For most, Medicaid's limited assistance supplements care provided by family members.
And there is more you may not know: While some believe Medicaid long-term care is plagued by wealthy enrollees who hide their assets to become eligible for public care, the vast majority of Medicaid LTSS recipients have been poor their entire lives. And those few who had assets when younger likely burned through their savings after long spells of costly medical and long-term care.
Keep all this mind as you watch Congress battle over the fate of Medicaid cuts.
House Republicans want to make $800 billion in program reductions over the next decade but Senate Republicans appear far less enthusiastic. President Trump's position remains unclear.
Those cuts could come through three basic mechanisms, with lots of versions of each: annual caps on the federal contribution to Medicaid, reducing the federal share of Medicaid spending, or imposing work requirements on beneficiaries.
The annual caps would be most draconian but appear least likely, given pushback from Republican governors.
Under current law, the federal government pays its share of Medicaid costs no matter how much those costs grow. In other words, the feds pay an average of 70 percent of a state's Medicaid costs, no matter how high they are or how fast they rise.
But GOP lawmakers want to limit that contribution though either block grants or per-capita caps. Either way, the federal government would pay only a fixed dollar amount of Medicaid costs, rather than a percentage of its expenses.
Block grants could be adjusted each year by Congress, rather than rising automatically.
The first Trump Administration proposed a per-enrollee cap, though it went nowhere.
Another option would lower the federal contribution percentage. Currently, the feds pay a minimum of 50 percent of a state's Medicaid costs. Congress could reduce the federal share or, more likely, eliminate the minimum 50 percent federal match, which would save about $500 billion over 10 years. Thanks to a complex formula, several high-income (mostly Democratic) states fall below that 50 percent threshold.
Any version of these changes would sharply reduce the amount the federal government pays for Medicaid, forcing states to either raise taxes to fund more themselves, cut benefits, or limit eligibility to save money.
Shrinking federal funding could have important implications for Medicaid LTSS. For instance, states are mandated by law to pay for long-term care in nursing homes but not for home care benefits, which are an optional benefit. If Medicaid funding is cut, states still must provide nursing home care but could drop or reduce optional home care.
A work requirement would focus on beneficiaries rather than on federal payments.
The first Trump Administration made work requirements optional, but this time Congress could mandate such a requirement.
The mandate would exempt older adults and people with disabilities, but what about their family caregivers?
It matters because many family caregivers likely are on Medicaid. Nearly 40 percent of White and more than half of Black family caregivers report spending more than 40 hours a week aiding a frail relative. A 2021 survey by the Rosalynn Carter Institute found 40 percent of employed family caregivers had to reduce their hours to support a loved one and nearly one in five quit their jobs. And those most likely to do so are low-income workers who might get caught up in a Medicaid work requirement.
Some versions of prior federal legislation would protect family caregivers, while others would not. And even with some protection, such a law would raise many difficult questions. Imagine two siblings caring for their mother. Which of them would be exempt from the Medicaid work requirement?
While many of the Medicaid cuts on the table would not directly affect older adults, people with disabilities, and their families, they are likely to have powerful indirect impacts. Keep it in mind as you watch what Congress does to the program.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kamala Harris' latest Stephen Colbert flop shows exactly what's wrong with both of them
Kamala Harris' latest Stephen Colbert flop shows exactly what's wrong with both of them

New York Post

time12 minutes ago

  • New York Post

Kamala Harris' latest Stephen Colbert flop shows exactly what's wrong with both of them

Kamala Harris' visit Thursday to Stephen Colbert's 'Late Show' was a fine reminder of why both of them are failures. Mind you, this marked Harris' eighth Late Show appearance — one more illustration of the futility of doing the same thing over and over and somehow expecting different results. What made her think this would help promote her new book? Advertisement The marquee moment was her inability to say who's leading the Democratic Party just now — which was actually simple honesty, since neither Dems nor Republicans have clear leaders these days unless it's a sitting president. But she couldn't explain that simple truth, nor did Colbert show any sign of getting it as he pushed for an answer. Her incoherence was part of another classic Kam performance, full of word salads and non-answers. Advertisement So why did Colbert even bring her on a supposed comedy show? Because he's followed most of the late-night crew down the 'we need to promote liberal politics' toilet, of course — hosting 176 Dem politicians and one Republican since 2022, and hewing one side of the aisle every minute in between. That formula earned him cancellation and may well take out all his peers. It's another puzzle of modern life that so much of the entertainment industry somehow forgot that sanctimoniousness (political or otherwise) is the enemy of humor.

The Supreme Court just dropped a hint about its next big Voting Rights Act case
The Supreme Court just dropped a hint about its next big Voting Rights Act case

Politico

time13 minutes ago

  • Politico

The Supreme Court just dropped a hint about its next big Voting Rights Act case

The order came in a case challenging Louisiana's congressional map, which contains two majority-Black districts out of the state's six House seats. The court heard arguments in the case in March and had been expected to rule by June. But on June 27, the justices punted the case into their next term and ordered that it be reargued. Now, Friday's order loosely sketches the terrain on which the justices want further arguments: the claim that the longstanding practice of drawing majority-minority districts under the Voting Rights Acts may be unconstitutional because of its focus on race in drawing district lines. The voters challenging Louisiana's map had already advanced that constitutional claim in the case, but the justices' call for further briefing on the issue suggests they want to consider the claim more fully. Section 2 of the Voting Rights Act, a landmark law passed during the civil rights era, generally prohibits race-based discrimination in voting laws and practices. In redistricting, the law is used to protect against racial gerrymandering that would unfairly dilute the voting power of racial and ethnic minority voters. States across the country routinely seek to comply with Section 2 by drawing congressional districts where minority voters can elect their chosen candidates. Louisiana's previous map contained only one majority-Black district, even though Black residents make up about a third of the state's population. After a court struck down that map for likely violating the Voting Rights Act because it diluted the power of Black voters, the state's Republican-controlled legislature drew the new map with two majority-Black districts. A group of voters — who self-identified as non-Black — challenged the new map. That's the case now before the Supreme Court. A ruling overturning the current map could result in Republicans picking up an additional congressional seat in Louisiana. The state's two majority-Black districts are both represented by Democrats, while the other four districts are represented by Republicans.

Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say

CBS News

time13 minutes ago

  • CBS News

Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say

Pfizer CEO Albert Bourla is among those expected at a fundraiser President Trump is attending Friday at his golf club in Bedminster, New Jersey, sources told CBS News. The fundraiser for the pro-Trump super political action committee MAGA Inc. aims to raise about $25 million, one of the sources said. One day prior to the event, Mr. Trump sent letters to pharmaceutical companies, including Pfizer, demanding they lower U.S. drug prices to more evenly match what other countries pay. The White House's letters to 17 drug companies, including AstraZeneca, Bristol Myers Squibb, Eli Lilly, Johnson & Johnson and Sanofi, asked for commitments within 60 days to sell drugs for Medicaid patients and all new drugs at "most favored nation" rates. The president posted images of the letters to Truth Social. Mr. Trump signed an executive order in May telling federal officials to draw up "most favored nation" regulations unless pharmaceutical companies made progress toward cutting prices. This week's letters — which were addressed to Bourla and the other CEOs — accused the drugmakers of promising "more of the same" since then. The president said Friday he's "gone to war with the drug companies and, frankly, other countries" on the drug price issue. "I think we're going to be very successful fairly soon. We'll have drug prices coming down by 500, 600 800 even 1,200 percent," Mr. Trump said in an interview with Newsmax on Friday afternoon. The high cost of prescription drugs has vexed both parties for decades. Proposals to tie drug prices for U.S. patients to the typically much-lower rates charged in other developed countries have floated around for years, but the idea has faced some legal pushback. Meanwhile, drugmakers argue price caps could discourage innovation by making it harder to pay for research and development for new drugs. The industry also argues that Americans tend to have access to more groundbreaking drugs than residents of foreign countries with stricter price regulations — and says high drug prices are just one part of a broader trend of higher healthcare spending in the U.S. Bourla has engaged with Mr. Trump in the past. Pfizer was one of the drugmakers that was picked to rapidly develop COVID-19 vaccines in the first Trump administration's "Operation Warp Speed." And two weeks before Mr. Trump's second inauguration, Bourla and other Pfizer executives traveled to Mar-A-Lago for meetings, the Financial Times has previously reported. CBS News has reached out to Pfizer and the White House for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store